Trial Profile
A Phase IIIb, multicenter, double-masked, randomized clinical trial comparing the efficacy and safey of Ranibizumab intravitreal injections versus Dexamethasone intravitreal implant in patients with visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jul 2021
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Dexamethasone
- Indications Central retinal vein occlusion; Retinal oedema
- Focus Therapeutic Use
- Acronyms COMRADE-C
- 22 May 2017 New trial record